Lexeo Therapeutics, Inc. Common StockLXEONASDAQ

Revenue (LTM)

Net Income (LTM)

$-98M

-48.1% YoY

Free Cash Flow

$-82M

Revenue CAGR (5Y)

—

—Marginsstable

FCF($0.1B)

Unprofitable

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Revenue	1	2↑219.6%	1↓60.5%	0	0
Gross Profit	1	2↑219.6%	1↓60.5%	0	0
Operating Income	-5	-51↓1003.7%	-61↓19.5%	-69↓13.2%	-106↓54.4%
Net Income	-5	-51↓882.4%	-59↓17.1%	-66↓12.0%	-98↓48.1%
EBITDA	-5	-51↓1003.1%	-58↓14.7%	-64↓10.9%	-96↓49.5%
EPS Diluted	-0.20	-2.01↓905.0%	-2.40↓19.4%	-2.49↓3.8%	-3.09↓24.1%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Cash & Equivalents	29	136↑362.5%	77↓43.1%	121↑57.1%	35↓71.2%
Total Current Assets	29	137↑364.8%	80↓41.4%	124↑55.3%	126↑1.5%
Total Assets	29	137↑365.4%	97↓29.1%	140↑44.0%	147↑5.1%
Total Current Liabilities	1	7↑967.6%	14↑92.6%	17↑20.1%	23↑32.5%
Total Liabilities	35	192↑450.7%	210↑9.1%	26↓87.5%	30↑14.6%
Total Equity	-6	-56↓904.3%	-113↓103.1%	114↑200.5%	117↑2.9%
Total Debt	0	0	13	12↓13.7%	10↓14.7%
Net Debt	-29	-136↓362.5%	-64↑53.0%	-110↓72.0%	-25↑77.2%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Operating Cash Flow	-3	-44↓1310.0%	-55↓23.5%	-59↓9.0%	-81↓36.4%
Capital Expenditure	0	-0	-1↓379.3%	-0↑81.7%	-0↓191.5%
Free Cash Flow	-3	-44↓1316.0%	-55↓25.0%	-60↓7.6%	-82↓36.8%
Stock-Based Comp	0	0	2↑361.4%	3↑70.9%	12↑309.9%
Net Change in Cash	29	106↑264.1%	-55↓151.9%	44↑179.8%	-86↓295.9%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance